^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CAR-T Targeting Nectin4/FAP
i
Other names: CAR-T Targeting Nectin4/FAP, CAR-T therapy for nectin4-positive malignant solid tumor, Fourth-generation CAR-T Cells (IL7 and CCL19 or / and IL12) Targeting Nectin4/FAP
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Zhejiang Qixin Biotech
Drug class:
FAP-targeted CAR-T immunotherapy, Nectin-4-targeted CAR-T immunotherapy
›
